New thyroid drug shows promise in phase 2 trial
NCT ID NCT05712421
First seen Jan 06, 2026 · Last updated May 22, 2026 · Updated 24 times
Summary
This study tested a new hormone replacement therapy called North Star against the standard drug levothyroxine for people with an underactive thyroid (hypothyroidism). 303 adults who were already stable on levothyroxine took part to see if North Star could control their thyroid hormone levels just as well. The goal was to find the right dose of North Star to keep thyroid-stimulating hormone (TSH) in the normal range.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOTHYROIDISM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Neuvosyn Investigational Site
Birmingham, Alabama, 35209, United States
-
Neuvosyn Investigational Site
Canoga Park, California, 91304, United States
-
Neuvosyn Investigational Site
Greenbrae, California, 94904, United States
-
Neuvosyn Investigational Site
Toluca Lake, California, 91602, United States
-
Neuvosyn Investigational Site
Farmington, Connecticut, 06030, United States
-
Neuvosyn Investigational Site
Boca Raton, Florida, 33434, United States
-
Neuvosyn Investigational Site
Miami, Florida, 33144, United States
-
Neuvosyn Investigational Site
Miami, Florida, 33145, United States
-
Neuvosyn Investigational Site
Miami, Florida, 33155, United States
-
Neuvosyn Investigational Site
Miami, Florida, 33174, United States
-
Neuvosyn Investigational Site
Miami, Florida, 33179, United States
-
Neuvosyn Investigational Site
Sunrise, Florida, 33351, United States
-
Neuvosyn Investigational Site
Acworth, Georgia, 30101, United States
-
Neuvosyn Investigational Site
Atlanta, Georgia, 30318, United States
-
Neuvosyn Investigational Site
Columbus, Georgia, 31904, United States
-
Neuvosyn Investigational Site
Sugar Hill, Georgia, 30024, United States
-
Neuvosyn Investigational Site
Saginaw, Michigan, 48602, United States
-
Neuvosyn Investigational Site
Gladstone, Missouri, 64118, United States
-
Neuvosyn Investigational Site
Williamsville, New York, 14221, United States
-
Neuvosyn Investigational Site
Denver, North Carolina, 28037, United States
-
Neuvosyn Investigational Site
Winston-Salem, North Carolina, 27103, United States
-
Neuvosyn Investigational Site
Beavercreek, Ohio, 45440, United States
-
Neuvosyn Investigational Site
Columbus, Ohio, 31904, United States
-
Neuvosyn Investigational Site
Georgetown, Texas, 78628, United States
-
Neuvosyn Investigational Site
Houston, Texas, 77040, United States
-
Neuvosyn Investigational Site
Katy, Texas, 77450, United States
-
Neuvosyn Investigational Site
Katy, Texas, 77494, United States
-
Neuvosyn Investigational Site
Lewisville, Texas, 75067, United States
-
Neuvosyn Investigational Site
Paris, Texas, 75462, United States
-
Neuvosyn Investigational Site
Pearland, Texas, 77584, United States
-
Neuvosyn Investigational Site
Stafford, Texas, 77477, United States
Conditions
Explore the condition pages connected to this study.